Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,689 public trials 1,036 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Active, Not Recruiting

A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors

NCT05537740

Conditions
Advanced Solid Tumors, Breast Diseases, Breast Neoplasms, +30 more
Locations
  • The University of Chicago Medical Center - Hyde Park - Hematology & Oncology Chicago, Illinois, United States
  • UNC Hospitals - UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
  • START | San Antonio San Antonio, Texas, United States
  • South Texas Accelerated Research Therapeutics | START Rocky Mountain Region West Valley City, Utah, United States
View all 26 locations
View Trial Details
Active, Not Recruiting

A Study to Compare the Efficacy, Safety, Pharmacokinetics, and Immunogenicity Between SB27 and Keytruda in Subjects With Metastatic Non-squamous Non-small Cell Lung Cancer

NCT06348199

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • SB Investigative Site Banja Luka, Bosnia and Herzegovina
  • SB Investigative Site Mostar, Bosnia and Herzegovina
  • SB Investigative Site Sarajevo, Bosnia and Herzegovina
  • SB Investigative Site Curitiba, Brazil
View all 93 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer (NSCLC)

NCT04765059

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Silver Spring, Maryland, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Beijing, China
  • Research Site Beijing, China
View all 40 locations
View Trial Details
Active, Not Recruiting

A Study of Combination Therapy With Amivantamab and Cetrelimab in Participants With Metastatic Non-small Cell Lung Cancer

NCT05908734

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • City of Hope Duarte, California, United States
  • City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • Cancer and Blood Specialty Clinic Los Alamitos, California, United States
  • Providence Portland Medical Center Portland, Oregon, United States
View all 44 locations
View Trial Details
Active, Not Recruiting

Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors

NCT05887492

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +16 more
Locations
  • UCLA Hematology/Oncology Santa Monica, California, United States
  • SCRI at HealthOne Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT04487080

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Arizona Oncology Associates, PC - HAL Goodyear, Arizona, United States
  • Yuma Regional Medical Center Yuma, Arizona, United States
  • City of Hope Long Beach Elm Long Beach, California, United States
  • University of California Irvine Orange, California, United States
View all 269 locations
View Trial Details
Active, Not Recruiting

A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions

NCT04538664

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • City of Hope 2 Duarte, California, United States
  • University of California Irvine Orange, California, United States
  • UCLA Santa Monica, California, United States
  • Georgetown University Hospital Washington D.C., District of Columbia, United States
View all 232 locations
View Trial Details
Active, Not Recruiting

A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer

NCT04077463

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Irvine Orange, California, United States
  • UCSF Helen Diller Comprehensive San Francisco, California, United States
  • Stanford University Medical Center Stanford, California, United States
View all 78 locations
View Trial Details
Active, Not Recruiting

Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung Cancer

NCT02609776

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Duarte, California, United States
  • La Jolla, California, United States
  • Orange, California, United States
  • Santa Monica, California, United States
View all 69 locations
View Trial Details

Related conditions